1649421165 IV HOME INFUSION
Home Infusion Agency
Active
Basic Information
- Organization Name
- IV HOME INFUSION
- Enumeration Date
- October 2, 2008
- Last Update
- October 2, 2008
- Authorized Official
- MARIA S GONZALEZ COLLAZO
PRESIDENT
Phone: (787) 349-7631
Practice Location
- Address
- COND PRIMAVERA 2340
APT 25 CARR NO. 2
BAYAMON, PR 009610000 - Phone
- (787) 349-7631
Mailing Address
- Address
- COND PRIMAVERA 2340
APT 25 CARR NO. 2
BAYAMON, PR 009610000 - Phone
- (787) 349-7631
Specialties & Taxonomies
Specialty | Code | Classification | License | State | Primary |
---|---|---|---|---|---|
Home Infusion Agency | 251F00000X | Home Infusion | N/A | N/A | Primary |
Frequently Asked Questions
What is IV HOME INFUSION's NPI number?
IV HOME INFUSION's NPI number is 1649421165.
Which doctor has NPI number 1649421165?
The doctor with NPI number 1649421165 is IV HOME INFUSION.
What is IV HOME INFUSION's practice address?
IV HOME INFUSION's practice address is COND PRIMAVERA 2340, APT 25 CARR NO. 2, BAYAMON, PR, 009610000.
Which doctor practices at COND PRIMAVERA 2340, APT 25 CARR NO. 2, BAYAMON, PR, 009610000?
IV HOME INFUSION practices at COND PRIMAVERA 2340, APT 25 CARR NO. 2, BAYAMON, PR, 009610000.
What is IV HOME INFUSION's phone number?
IV HOME INFUSION's phone number is (787) 349-7631.
Who is (787) 349-7631?
(787) 349-7631 is the phone number for IV HOME INFUSION.
What is IV HOME INFUSION's specialty?
IV HOME INFUSION's specialty is Home Infusion Agency.
What type of doctor is IV HOME INFUSION?
IV HOME INFUSION is a Home Infusion Agency.
Is IV HOME INFUSION a Home Infusion?
Yes, IV HOME INFUSION is a Home Infusion.
Is IV HOME INFUSION still practicing?
Yes, IV HOME INFUSION is currently practicing.
Is IV HOME INFUSION accepting new patients?
IV HOME INFUSION may be accepting new patients. Please call their office at (787) 349-7631 to inquire about availability.
Is NPI 1649421165 still active?
Yes, NPI 1649421165 is currently active.
Where does IV HOME INFUSION practice?
IV HOME INFUSION practices in BAYAMON, PR.